The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation

被引:399
作者
Kedmi, Ranit [1 ,2 ]
Ben-Arie, Noa [1 ,2 ]
Peer, Dan [1 ,2 ]
机构
[1] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab Nanomed, IL-69978 Tel Aviv, Israel
关键词
Lipid-based nanoparticles; Immune activation; Interferon response; Cytokine induction; TLR4; DENDRITIC CELLS; SIRNA DELIVERY; LIPOPOLYSACCHARIDE; LIPOSOMES; TLR4; RNA; INTERFERENCE; INFLAMMATION; SUPPRESSION; DOXORUBICIN;
D O I
10.1016/j.biomaterials.2010.05.027
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Delivery of nucleic acids with positively charged lipid nanoparticles ((+)NPs) is widely used as research reagents and potentially for therapeutics due to their ability to deliver nucleic acids into the cell cytoplasm. However, in most reports little attention has been made to their toxic effects. In the present study, we performed comprehensive analyses of the potential toxicity associated with (+)NPs. Mice treated with (+)NPs showed increased liver enzyme release and body weight loss compared to mice treated with neutral or negatively charged NPs (()NPs), suggesting hepatotoxicity. Intravenous administration of (+) NPs induced interferon type I response and elevated mRNA levels of interferon responsive genes 15-25-fold higher than neutral and ()NPs in different subsets of leukocytes. Moreover, treatment with (+)NPs provoked a dramatic pro-inflammatory response by inducing Th1 cytokines expression (IL-2, IFN gamma and TNF alpha) 10-75-fold higher than treatment with control particles. Finally, we showed that activation of TLR4 might serve as the underlying mechanism for induction of an immune response when (+)NPs are used. These results suggest that a careful attention must be made when different types of (+)NPs are being developed as nanotherapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6867 / 6875
页数:9
相关论文
共 53 条
[1]   Development of Lipidoid-siRNA Formulations for Systemic Delivery to the Liver [J].
Akinc, Akin ;
Goldberg, Michael ;
Qin, June ;
Dorkin, J. Robert ;
Gamba-Vitalo, Christina ;
Maier, Martin ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
Roehl, Ingo ;
Leshchiner, Elizaveta S. ;
Langer, Robert ;
Anderson, Daniel G. .
MOLECULAR THERAPY, 2009, 17 (05) :872-879
[2]   Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies [J].
Apetoh, Lionel ;
Tesniere, Antoine ;
Ghiringhelli, Francois ;
Kroemer, Guido ;
Zitvogel, Laurence .
CANCER RESEARCH, 2008, 68 (11) :4026-4030
[3]   Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein Toll-Like Receptor 4-and Spleen Tyrosine Kinase-Dependent Activation of NADPH Oxidase 2 [J].
Bae, Yun Soo ;
Lee, Jee Hyun ;
Choi, Soo Ho ;
Kim, Sunah ;
Almazan, Felicidad ;
Witztum, Joseph L. ;
Miller, Yury I. .
CIRCULATION RESEARCH, 2009, 104 (02) :210-U147
[4]   Cancer - An inflammatory link [J].
Balkwill, F ;
Coussens, LM .
NATURE, 2004, 431 (7007) :405-406
[5]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[6]   Interfering with disease: a progress report on siRNA-based therapeutics [J].
de Fougerolles, Antonin ;
Vornlocher, Hans-Peter ;
Maraganore, John ;
Lieberman, Judy .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) :443-453
[7]   De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent [J].
de Visser, KE ;
Korets, LV ;
Coussens, LM .
CANCER CELL, 2005, 7 (05) :411-423
[8]   Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes [J].
Dokka, S ;
Toledo, D ;
Shi, XG ;
Castranova, V ;
Rojanasakul, Y .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :521-525
[9]   RNA interference is mediated by 21-and 22-nucleotide RNAs [J].
Elbashir, SM ;
Lendeckel, W ;
Tuschl, T .
GENES & DEVELOPMENT, 2001, 15 (02) :188-200
[10]   Formation and intracellular trafficking of lipoplexes and polyplexes [J].
Elouahabi, A ;
Ruysschaert, JM .
MOLECULAR THERAPY, 2005, 11 (03) :336-347